Riken Vitamin: Corporate Governance Report
Riken Vitamin: Notice of publication of the “Integrated Report 2024”
Riken Vitamin: Notice Regarding Establishment of Subsidiaries
Riken Vitamin: Notice regarding the establishment of a subsidiary
Riken Vitamin: Announcement of disposal of treasury stock through third-party allocation.
Riken Vitamin: Continuation and additional contributions to the stock compensation system for directors and the incentive plan for company executives.
Riken Vitamin: Announcements of individual stocks regarding the continuation and additional contribution to the performance-linked stock compensation system for company executives and the incentive plan for executing officers.
Riken Vitamin: Overview of Q1 2025 earnings report.
Riken Vitamin: Corporate Governance Report
Riken Vitamin: Notice regarding dividends from surplus funds
Riken Vitamin: 2024 financial results overview
Riken Vitamin: Notice regarding revisions to year-end dividend forecasts
RIKEN VITAMINS: Notice Concerning Results of Share Repurchase by ToSTNet-3 and Changes in Major Shareholders
RIKEN VITAMIN: Notice Concerning Repurchase of Treasury Shares and Repurchase of Treasury Shares through the Out-of-Witness Treasury Repurchase Trading System (ToSTNet-3)
RIKEN VITAMINS: Notice regarding dissolution of capital and business alliance
RIKEN VITAMINS: Notice Concerning Dissolution of Capital and Business Alliances
Riken Vitamin: Notice of Revisions to Consolidated Full-Year Results Forecast and Year-end Dividend Forecast
Riken Vitamin: Summary of Financial Results for the third quarter 2024
Riken Vitamin: Notice Regarding Recording of Extraordinary Income (Gain on Sale of Investment Securities)
Riken Vitamin: Notice Concerning the Recording of Gains (Extraordinary Profit) from the Sale of Investment Securities
No Data
No Data